The agency has given a thumbs up to Sanofi’s Merilog (insulin-aspart-szjj) as the first biosimilar to Novo Nordisk’s NovoLog for patients ... by prefilled pen in a 3 mL dose or in a multiple ...
Merilog has been approved as biosimilar to Novolog (insulin aspart ... The approval is for both a 3 milliliter or mL single-patient-use prefilled pen and a 10 mL multiple-dose vial.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback